Fonte: Fortune
AstraZeneca will pay $425 million upfront for EsoBiotec and may spend up to $575 million more in development and regulatory milestones, the companies said.
Ler na Fonte
Notícias Relacionadas
Lista de Notícias
AstraZeneca to buy cell therapy biotech for up to $1 billion
AstraZeneca
Fortune
há 53d
